The OncoNet Rhein-Main network strives to offer cancer patients access to novel therapies via ongoing clinical studies. Matching patients and studies is challenging due to the increasing complexity and continually evolving landscape of molecular data in oncology.
As a regionally networked partner of the Rhein-Main area, Molecular Health supports therapy decisions by clinicians and pathologists with the structured processing and interpretation of next-generations sequencing (NGS) tumor profiles. Partners of OncoNet Rhein- Main receive onsite training to incorporate MH Guide into their translation of molecular data into practicable treatment decisions.
The coverage in MH Guide of latest research findings, treatment recommendations, and ongoing clinical trials offer healthcare providers of the OncoNet Rhein-Main a rapid and accurate overview of approved and investigational therapy options. With detailed information about detected variants, all stakeholders can engage in multidisciplinary discussions to identify the best path for a patient based on a shared understanding of NGS data and, thus, offer patients individualized care.